AVITA Medical, Inc. (RCEL) Return on equity 2017–2024
AVITA Medical, Inc. (RCEL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1374.6%FY2024 · since FY2017: -90.8% → -1374.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1374.6% | -1302.5 pp |
| FY2023 | -72.1% | -40.7 pp |
| FY2022 | -31.5% | — |
| FY2020 | -23.0% | +35.1 pp |
| FY2019 | -58.1% | +62.4 pp |
| FY2018 | -120.5% | -29.7 pp |
| FY2017 | -90.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice